Stimwave Technologies launches new chronic pain trial for mini neurostim device

Stimwave Technologies launches a placebo-controlled trial of its miniature, wireless neuromodulation anti-pain device for treating chronic, non-specific-origin lower back pain.

Stimwave Technologies said it's launching a new clinical trial for its miniature, wireless neuromodulation anti-pain device for treating chronic, non-specific-origin lower back pain.

Stimwave Technologies

News Well, Clinical Trials, Neuromodulation/Neurostimulation, Pain Management

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/13gRLWu